Pulmonary Function Testing Systems Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

The Global Pulmonary Function Testing Systems Market reached USD 2.9 billion in 2024 and is on track to expand at a CAGR of 6.6% between 2025 and 2034. This rapid growth is fueled by continuous advancements in diagnostic technologies, an aging population, increased awareness of early disease detection, and improved healthcare infrastructure. With respiratory diseases becoming more prevalent, healthcare providers are prioritizing early diagnosis and efficient disease management, which is significantly boosting the demand for advanced pulmonary function testing systems. Innovations in compact, high-precision devices are making pulmonary assessments more accessible across various healthcare settings. The shift toward cost-effective and user-friendly diagnostic tools is shaping the industry, driving greater adoption in clinical and home-based environments.

Market growth is further supported by ongoing investments in medical technology and digital integration, enhancing the efficiency and reliability of pulmonary assessments. The increasing need for continuous respiratory monitoring is pushing manufacturers to develop devices with improved functionality and accuracy. The rise of wearable and remote monitoring solutions is transforming respiratory diagnostics, making them more convenient for both patients and healthcare professionals. As the industry moves toward personalized medicine, pulmonary function testing systems are evolving to provide more precise and patient-specific insights. Preventive care initiatives and widespread screening programs are accelerating adoption, ensuring steady expansion in the coming years.

Portable and compact diagnostic devices are experiencing significant demand due to their ease of use and ability to provide precise results in various healthcare environments. The handheld segment led the market, generating USD 1.7 billion in revenue in 2024. These cost-efficient devices are favored over larger, laboratory-based equipment, particularly by smaller healthcare facilities that require affordable yet accurate respiratory assessments. Their flexibility in delivering real-time testing has led to increased adoption across multiple medical applications. As manufacturers refine device performance and enhance user convenience, the industry is shifting toward digital connectivity and remote monitoring capabilities. The rising demand for accurate and accessible pulmonary function testing solutions is driving innovation, reinforcing their essential role in modern healthcare systems.

Chronic respiratory conditions are a major factor driving market expansion, with chronic diseases accounting for a substantial portion of demand. The chronic obstructive pulmonary disease (COPD) segment held a 39.8% market share in 2024. The rising incidence of pulmonary disorders due to environmental pollutants and lifestyle factors has made pulmonary function testing a crucial part of routine healthcare. As chronic respiratory diseases become more prevalent, healthcare providers are investing in advanced diagnostic equipment to facilitate early intervention. The importance of early detection in slowing disease progression is increasing demand for precise pulmonary assessments. Advancements in testing technology are improving efficiency, thus offering better monitoring and disease management solutions. Expanding healthcare infrastructure is also improving access to state-of-the-art pulmonary function testing devices, driving overall market growth.

The US pulmonary function testing systems market was valued at USD 1.3 billion in 2024 and is projected to grow at a CAGR of 5.4% through 2034. As a global leader in medical technology, the US continues to integrate high-precision diagnostic tools into healthcare institutions, improving accuracy and efficiency in pulmonary assessments. The widespread adoption of digital and wireless-enabled devices is further streamlining pulmonary function testing, increasing overall market demand. With strong investments in healthcare innovation and a rising focus on early disease detection, the US market is well-positioned for consistent growth over the next decade.


Chapter 1 Methodology and Scope
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360° synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increase in prevalence of chronic respiratory diseases
3.2.1.2 Technological advancements
3.2.1.3 Favourable government initiatives
3.2.2 Industry pitfalls and challenges
3.2.2.1 High cost associated with pulmonary function testing devices
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Reimbursement scenario
3.7 Pricing analysis
3.8 Porter’s analysis
3.9 PESTEL analysis
3.10 Gap analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 — 2034 ($ Mn)
5.1 Key trends
5.2 Handheld
5.3 Tabletop
Chapter 6 Market Estimates and Forecast, By Test Type, 2021 — 2034 ($ Mn)
6.1 Key trends
6.2 Spirometry
6.3 Exercise stress test
6.4 Lung volume test
6.5 High altitude simulation testing
6.6 Gas diffusion test
6.7 Other test types
Chapter 7 Market Estimates and Forecast, By Application, 2021 — 2034 ($ Mn)
7.1 Key trends
7.2 Chronic obstructive pulmonary disease
7.3 Asthma
7.4 Chronic shortness of breath
7.5 Pulmonary fibrosis
7.6 Other applications
Chapter 8 Market Estimates and Forecast, By End Use, 2021 — 2034 ($ Mn)
8.1 Key trends
8.2 Hospitals & clinics
8.3 Diagnostic centers
8.4 Homecare settings
8.5 Other end users
Chapter 9 Market Estimates and Forecast, By Region, 2021 — 2034 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
Chapter 10 Company Profiles
10.1 Baxter
10.2 CHEST M.I
10.3 COSMED
10.4 ECO MEDICS
10.5 FUKUDA SANGYO
10.6 GANSHORN SCHILLER GROUP
10.7 Geratherm Respiratory
10.8 medical equipment europe
10.9 MGC DIAGNOSTICS
10.10 MINATO MEDICAL SCIENCE
10.11 MORGAN
10.12 ndd Medical Technologies
10.13 PHILIPS
10.14 Vitalograph
10.15 Vyaire MEDICAL
 

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings